According to our new research study on "Breath Analyzers Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Technology, Application, End User, and Geography," the breath analyzers market is expected to grow from US$ 1,188.76 million in 2022 to US$ 3,685.94 million by 2030; it is estimated to register a CAGR of 15.19% during the forecast period. The growing alcohol consumption and alcohol-impaired accidents and false results by breath analyzers are the noteworthy factors driving the breath analyzers market growth. 
 
Growing Alcohol Consumption and Alcohol-Impaired Accidents 

According to the World Data report published in 2022, the average consumption of alcohol across the world is 6.182 liters per person. The World Health Organization (WHO) reveals that excessive alcohol consumption results in 3 million deaths every year (representing 5.3% of the overall deaths worldwide), causing harm to the well-being and health of people. Additionally, 5.1% of the global burden of disease and injury caused to an individual due to alcohol drunken driving causes social and economic losses to individuals and society. Excessive alcohol consumption results in road traffic crashes and accidents. The US Department of Health & Human Services report reveals 11,654 deaths due to motor vehicle crashes caused by alcohol-impaired drivers, accounting for 30% of all traffic-related deaths in the US in 2020. There was a 14.3% rise in 2020 compared to alcohol-impaired deaths in 2019. Also, the annual estimated healthcare cost of treatments and deaths due to accidents caused by alcohol-impaired drivers was US$ 123.3 billion in 2020.  

The National Transportation Safety Board (NTSB) announced the installation of in-vehicle alcohol detection technology, lowering the blood alcohol concentration limit to 0.05 g/dl or lower, to prevent alcohol and other drug-impaired driving crashes after an incident happened in California that killed nine people, including seven children. Therefore, the rising number of deaths due to accidents caused by drunken driving accelerates demand for breath analyzers. 

End User-Based Insights

In terms of end user, the breath analyzer market is segregated as law enforcement agencies, hospitals & diagnostic centers, and others. The hospitals & diagnostic centers segment held a larger share of the market in 2022 and is anticipated to register a higher CAGR during 2022–2030.

Hospitals and diagnostic centers use breath analysis to study and detect breath biomarkers to diagnose any disease. Volatile organic compounds (VOCs) are breath biomarkers generated in the body that travel through the bloodstream, reach the alveolar interface, and are eventually expelled through exhalation. Analyzing exhaled breath for VOCs presence could reveal the health status of an individual, indicating whether they are diseased or healthy. Numerous studies have been carried out in laboratory settings to establish the efficiency and accuracy of breath analyzers in disease diagnosis. For instance, a team of researchers at the S. N. Bose National Centre for Basic Sciences (SNBNCBS) in Kolkata, an autonomous institute under the Department of Science & Technology of the Government of India, developed ‘Pyro-Breath.’ It is a new-generation noninvasive diagnostic strategy for an early and quick diagnosis of Helicobacter pylori infection. The technology utilizes a residual gas analyzer (RGA) to scan specific 'Breath-Print Masses (BPMs)' in real time. 

Disease diagnosis using an electronic nose (E-nose) has also gained attention due to its ability to produce susceptible, rapid, and low-cost detection systems with reliable and reproducible results. For instance, in an article published by PubMed Central in August 2022, a study was carried out on 45 participants to assess the role of polymer-based e-nose in the detection of head and neck cancer using Cyranose 320 E-nose (Sensigent, Pasadena, CA, USA). 
Additionally, the E-Nose Breathalyzer, developed at the National Aeronautics and Space Administration’s (NASA) Ames Research Center in Silicon Valley, was presented to David Grant USAF Medical Center on October 21, 2020, at Travis Air Force Base.

Ongoing research and developments by research and diagnostic centers fuel the breath analyzer market growth for the segment.

Thermo Fisher Scientific Inc, Alcolizer Pty Ltd, Lifeloc Technologies Inc, Now Group UK Ltd, Dragerwerk AG & Co KGaA, Abbott Laboratories, Honeywell International Inc, KHN Solutions LLC, Bedfont Scientific Ltd, and Intoximeters Inc. are among the leading companies operating in the breath analyzers market. 

 
The global breath analyzers market is segmented into technology, application, and end user. Based on technology, the market is segregated as fuel cell technology, semiconductor sensor, infrared spectroscopy, and others. In terms of application, the breath analyzers market is segmented into drug abuse detection, alcohol detection, and medical applications. The breath analyzers market, by end user, is segmented into law enforcement agencies, hospital & diagnostic centers, and others. By geography, the breath analyzers market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and Rest of APAC), Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of MEA), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com